Lv41
414 积分 2021-04-09 加入
Gene copy deletion of STK11, KEAP1, and SMARCA4: clinicopathologic features and association with outcomes to immunotherapy +/- chemotherapy in nonsquamous non-small cell lung cancer
2天前
已完结
Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
20天前
已完结
HER2-targeted therapies — a role beyond breast cancer
1个月前
已完结
HER2 aberrations in cancer: Implications for therapy
1个月前
已完结
HER2-targeted therapies beyond breast cancer — an update
1个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
1个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
1个月前
已完结
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA
1个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
1个月前
已完结
Lazertinib Versus Osimertinib in Previously Untreated EGFR-mutant Advanced NSCLC: A Randomized, Double-blind, Exploratory Analysis From MARIPOSA
1个月前
已完结
皖公网安备34019202002308
